Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 2201–2250 of 18616
On March 17, 2025, Avanos Medical, Inc. (the “Company”) announced the appointment of David Pacitti as the Company’s Chief Executive Officer, effective April 14, 2025.
on March 17, 2025, the Board of Directors of the Company appointed Alissa Vickery to serve as the Company’s interim CFO, effective immediately upon Mr. Panther's departure.
Tom Panther notified Corpay, Inc. (the “Company”) of his decision to resign as Chief Financial Officer (“CFO”) effective March 15, 2025.
On March 17, 2025, Richard Vance, President and Chief Executive Officer and director of the Company, retired from the Company and resigned from the Board.
On March 17, 2025, the Board of Directors (the “ Board”) of Highlands REIT, Inc. (the “ Company”) appointed Robert J. Lange to serve as Chief Executive Officer, President, and Secretary of the Company, effective immediately.
On March 17, 2025, the Company’s Board of Directors determined to make Mr. Sam Davis the Company’s permanent Chief Executive Officer, and approved a change in Mr. Davis’s title to President and Chief Executive Officer, effective immediately.
appointed Michael Carlet, the Company’s Executive Vice President and Chief Financial Officer, to also serve as the Company’s principal accounting officer
appointed Lip-Bu Tan as Chief Executive Officer (“CEO”) and as a director of the Company, effective as of March 18, 2025
In connection with Lip-Bu Tan’s appointment as Intel’s Chief Executive Officer effective March 18, 2025, Ms. Holthaus and Mr. Zinsner will cease to serve as Interim Co-CEOs as of such date.
In connection with Lip-Bu Tan’s appointment as Intel’s Chief Executive Officer effective March 18, 2025, Ms. Holthaus and Mr. Zinsner will cease to serve as Interim Co-CEOs as of such date.
Jeffrey J. Scissons has been named Vice President, Chief Financial Officer and Corporate Treasurer (“CFO”) of ALLETE, Inc. (the “Company”), effective as of March 11, 2025.
Robert Starr, the Company’s Executive Vice President and Chief Financial Officer will assume the role of Principal Accounting Officer on an interim basis until a successor is named.
Immediately following the conclusion of the AGM, Joakim Weidemanis succeeded George Oliver as the Company's Chief Executive Officer and principal executive officer
Immediately following the conclusion of the AGM, Joakim Weidemanis succeeded George Oliver as the Company's Chief Executive Officer and principal executive officer
Effective March 14, 2025, the Board of Directors (the “Board”) of Sterling Infrastructure, Inc. (the “Company”) appointed Ronald A. Ballschmiede, the Company’s Executive Vice President and former Chief Financial Officer and Chief Accounting Officer, as the Company’s interim Chief Financial Officer and Chief Accounting Officer.
Upon approval of the Board, Sharon R. Villaverde ceased serving as Chief Financial Officer and Chief Accounting Officer, without cause, on March 14, 2025.
On March 11, 2025, Rasmus Holm-Jorgensen, the Company’s Chief Financial Officer, notified the Company of his decision to step down from his position, effective April 1, 2025, for personal reasons to pursue another opportunity with a company based in Europe, allowing him to spend more time near his family.
On March 14, 2025, Acrivon Therapeutics, Inc. (the “Company”) appointed Adam Levy, Ph.D., M.B.A., to the position of Chief Financial Officer, effective as of April 1, 2025 (the “Effective Date”).
As previously announced by Enovis Corporation (the “Company”), on February 25, 2025, Matthew L. Trerotola notified the Board of Directors (the “Board”) of the Company of his intention to retire from his current position as Chief Executive Officer (“CEO”) of the Company, effective upon his successor being appointed by the Board and assuming the position as CEO of the Company (the “Appointment Date”).
As previously announced, Richard Dierker, the Company’s current Executive Vice President, Chief Financial Officer and Head of Business Operations, will commence his role as the Company’s Chief Executive Officer on April 2, 2025, succeeding Matthew T. Farrell upon Mr. Farrell’s retirement, and Mr. McChesney will succeed Mr. Dierker as CFO.
On March 14, 2025, Church & Dwight Co., Inc. (the “Company”) announced that Lee McChesney will be elected as Executive Vice President and Chief Financial Officer of the Company, effective on March 24, 2025.
succeeding Matthew T. Farrell upon Mr. Farrell’s retirement
On March 11, 2025, the Board appointed Ms. Yu-Fang Chiu to serve as Chief Executive Officer, Chief Financial Officer, and Chairman of the Board, to serve until the Company’s annual meeting to be held in 2028 and until her successor is duly elected and qualified or until her earlier death, resignation or removal.
On March 11, 2025, Mr. Shibasish Sarkar notified International Media Acquisition Corp. (the “Company”) of his decision to resign as the Chief Executive Officer and as Class I director of the Company’s board of directors (the “Board”) effective immediately.
DeeAnn Cain, CPA, is a strategic financial leader with 15+ years of experience optimizing financial processes and driving technology innovation.
Amanda Roark, who previously held the CFO role was released from her obligations under the CFO role effective February 28, 2025.
Effective as of March 5, 2025, the following individual(s) appointed by the Board of Directors to the positions indicated of the Registrant: Name Age Position James W. Zimbler 59 President/CEO and Director
Effective as of March 5, 2025, the following has resigned as President /CEO of the Registrant, but shall remain as a member of the Board of Directors.
Valarie Sheppard, a member of the Company’s Board of Directors (the “Board”) will assume the position of the Company’s Interim Chief Financial Officer, effective March 14, 2025.
Sunit Patel resigned as Chief Financial Officer and Principal Financial Officer of Ibotta, Inc. (the “Company”), effective March 14, 2025, and he will remain with the Company through March 28, 2025.
(2) Ellis Smith – re-appointed as Interim CEO, as he meets the Colorado Marijuana Enforcement Division requirements, and is currently listed as “beneficial owner”, and will remain appointed until Mr. Cleghorn meets said requirements.
(3) Shanna Nance - secretary and interim CFO, to last approximately six months.
Lee B. McChesney, Senior Vice President and Chief Financial Officer of the Company, has notified the Company that he will resign effective March 21, 2025, to pursue another business opportunity.
the Company’s Executive Director of Financial Planning and Analysis and Strategy, Elyse L. Brody, will act as interim Chief Financial Officer effective March 21, 2025, in addition to her current role with the Company.
Mr. Newell ceased his role as the Company’s President and CEO, effective March 13, 2025
Effective as of the Newell Separation Date, the Board appointed Jane Chung, the Company’s President and Chief Operating Officer, to succeed Mr. Newell as Chief Executive Officer.
On March 7, 2025, the Board appointed Barbara M. Lilley, 66, the Controller of Ranor, Inc., one of the Company’s operating subsidiaries, to serve as Interim Chief Financial Officer, principal financial officer and principal accounting officer, in addition to her current duties, while the Board is engaged in a search to identify the Company’s next Chief Financial Officer.
Mr. Shen will no longer be the principal financial officer and principal accounting officer of the Company, as Ms. Lilley assumed those responsibilities upon her appointment as Interim Chief Financial Officer.
Effective April 11, 2025, Chad Holmes, the Company’s Executive Vice President and Chief Corporate Development Officer, will assume the role of interim Chief Financial Officer while the Company, with the assistance of a leading executive search firm, conducts a search for a permanent replacement.
On March 11, 2025, Daniel K. Mahoney notified CRA International, Inc. (the “Company”) that he will resign from his role as the Company’s Chief Financial Officer, Executive Vice President and Treasurer, effective April 11, 2025, for a new opportunity outside of the consulting industry.
Ann M. Dennison will serve as Executive Vice President, Chief Financial Officer, The Cigna Group
On March 11, 2025, Mr. Samuel M. Sato informed the Company that he is retiring as President and Chief Executive Officer and as a member of the Board of Directors (the “Board”), with such retirement to be effective on April 25, 2025.
The Board appointed Mr. Stephen L. Schlecht as Interim Chief Executive Officer of the Company in addition to his role as Senior Advisor to the Company, effective April 25, 2025
On March 13, 2025, Vicarious Surgical Inc. (the “Company”) announced that Sarah Romano was appointed by the Board of Directors of the Company (the “Board”) as Chief Financial Officer and Treasurer of the Company, effective April 1, 2025
Effective March 13, 2025, Butler National Corporation (the “Company”) appointed Mickie Lamphere, an employee of Morgan Hunter, an executive services firm, to the position of Interim Chief Financial Officer.
the board of directors of the Company appointed David Natan as the Company’s Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer, in his capacity as a non-employee consultant, effective March 12, 2025.
Ron Levy resigned from his position as interim Chief Financial Officer and relinquished the roles of Principal Financial Officer and Principal Accounting Officer of the Company, which Mr. Natan has now assumed.
Mr. Patel notified the Company’s Board of Directors of his intention to resign his position as Interim Principal Financial/Accounting Officer effective as of the Effective Date.
On March 13, 2025, the Board of Directors of Scienture Holdings, Inc. (the “Company”) appointed Eric Sherb to serve as the Company’s Chief Financial Officer effective as of March 13, 2025
On March 7, 2025, effective upon consummation of the Sale and the transfer of the Company’s business to Purchaser, the Company terminated the employment of Ryan Jenkins, Chief Financial Officer.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.